This test is most useful if any of these apply to you.
Flame retardants and plasticizers from your couch, car interior, electronics, and household dust make their way into your body whether you notice it or not. DPhP (diphenyl phosphate) is what shows up in your urine after your body breaks down a family of these chemicals called aryl organophosphate flame retardants.
Roughly 92% of Americans aged 6 and older have detectable DPhP in their urine, according to NHANES data. This test gives you a personal exposure number to compare against population trends and to track how your home environment, work setting, and habits move that number over time.
DPhP is not a chemical your body makes on its own. It is a metabolite, meaning the leftover product after your liver and kidneys break down certain aryl organophosphate esters and flush them through urine. The most common parent chemicals are triphenyl phosphate (TPHP), 2-ethylhexyl diphenyl phosphate (EHDPP), and resorcinol bis-diphenyl phosphate (RDP), which are added to plastics, electronics, foam furniture, and nail polish to slow ignition or improve flexibility.
Because DPhP comes from several different parent chemicals, a high level tells you the body is processing aryl organophosphate flame retardants but does not pinpoint which specific product or exposure source is responsible. Reviewers describe DPhP as the main biotransformation product of this whole chemical family, which is exactly why it is the go-to urinary marker in population studies.
Indoor dust is the dominant source for most people. Aryl organophosphates leach out of foam padding, electronics casings, and treated fabrics, settle into dust, and reach you through inhalation, hand-to-mouth contact, and skin absorption. Children consistently carry higher levels than adults, with one mother-child cohort reporting a median of 1.1 ng/mL in kids versus 0.51 ng/mL in their mothers, roughly twice as high.
Occupation matters, too. Workers in chemical manufacturing, foam production, roofing, and electronic waste recycling carry markedly higher DPhP than the general population. In one e-waste recycling study, DPhP was the most abundant non-chlorinated organophosphate metabolite measured.
In a study of 51 adults, higher urinary DPhP was associated with higher total T4 (the main thyroid hormone), particularly in women. The same study did not find clear shifts in TSH or free T4 specifically tied to DPhP. The signal is exploratory rather than definitive, but it raises the possibility that aryl organophosphate exposure nudges the thyroid axis in women.
An NHANES analysis of 1,580 US adults found that higher DPhP was linked to lower total cholesterol and lower HDL cholesterol (the cardio-protective fraction). The direction is unusual, since lower total cholesterol is generally seen as favorable while lower HDL is not. The authors interpret this as a signal that aryl organophosphate exposure may disrupt lipid metabolism rather than simply improve it.
This is exactly the kind of result that should not be read as a single good-or-bad number. DPhP is a phenotype indicator that can move alongside lipid changes in either direction, depending on which lipid fraction you look at. Interpret it as a signal that your exposure profile may be interacting with lipid biology, not as a verdict on cardiovascular risk by itself.
In a study of 231 residents of an electronic-waste recycling area in China, higher urinary DPhP correlated with higher 8-hydroxy-2-deoxyguanosine (8-OHdG), a marker of oxidative damage to DNA. A separate biomonitoring study of 152 adults reported the same pattern. Higher chemical exposure tracks with more oxidative wear on cellular DNA.
Two cohort studies in pregnant women found that higher maternal DPhP during pregnancy was linked to lower IQ and working memory scores in their children, and to more externalizing and behavioral symptoms in another cohort. These are observational findings in human pregnancies, and causality has not been established, but they are the strongest reason researchers consider aryl organophosphate exposure during pregnancy a concern.
There are no clinical decision thresholds for DPhP from any major guideline. The numbers below come from population biomonitoring studies, mainly NHANES and similar cohorts, and are intended as orientation against the general population, not as medical targets. Your lab will likely use slightly different units and report against its own reference distribution.
| Population Tier | Approximate Urinary DPhP | What It Suggests |
|---|---|---|
| General US adult range | Most values fall under 2 µg/L | Typical background exposure consistent with NHANES 2013 to 2014 |
| Children and adolescents | Often 1.1 ng/mL or higher | Higher hand-to-mouth and dust contact than adults |
| Occupational or e-waste settings | Markedly elevated, sometimes hundreds of µg/L | Active workplace exposure that warrants source investigation |
Source: NHANES 2013 to 2014 (Ospina et al.), Norwegian mother-child cohort (Cequier et al.), and Chinese e-waste recycling study (Lu et al.). Compare your results within the same lab over time for the most meaningful trend, since assay methods and reporting units vary.
DPhP levels swing meaningfully from day to day. Repeated-measure studies show that a single spot urine can misclassify your usual exposure, with within-person variability that researchers describe as poor short-term reproducibility. A 24-hour pooled sample, or two to three spot samples taken over a few weeks, gives a more accurate read than a one-off test.
DPhP is best understood as a moving exposure number, not a one-time diagnosis. Get a baseline, then retest in 3 to 6 months after making changes to your indoor environment (new vacuum routines, dust mitigation, replacing old foam furniture, work hygiene changes). Annual retesting after that is reasonable for anyone who wants to monitor their exposure profile alongside other environmental markers.
Because DPhP responds to recent rather than long-term exposure, two readings months apart give you a much better picture than one. If your number drops after you change your environment, that is real-world feedback that the change worked. If it stays high despite changes, the source has not been found yet.
If your DPhP comes back well above the population median, the next step is not panic but investigation. The number alone does not tell you which product is the source. Look at the highest-yield exposure categories first: foam furniture older than 10 years, electronic equipment density in your bedroom and living spaces, frequency of household dusting and HEPA vacuuming, and occupational contact with treated plastics or electronics.
Pair an elevated DPhP with companion markers if you want a fuller exposure picture. 8-OHdG (a urinary marker of oxidative DNA damage) shows whether the exposure is creating measurable cellular wear. Other phthalate and bisphenol metabolites round out a broader environmental chemical profile. If your level is in the occupational range and you work with treated plastics, foam, or electronics, an occupational medicine specialist can help investigate workplace sources.
Evidence-backed interventions that affect your DPP level
Diphenyl Phosphate is best interpreted alongside these tests.